Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have revolutionized weight loss management, and researchers are now exploring how these medications can further transform obesity care and offer new possibilities for long-term weight management, according to a recent review article published in Endocrinology. Authors Lauren A. Jones and Daniel I. Brierley, PhD, both of the Centre for Cardiovascular...
Kids On the Move: Protecting Future Generations from Obesity
Leading pediatric endocrinologist and recipient of the Endocrine Society’s 2025 Outstanding Leadership in Endocrinology Laureate Award, Ilene Fennoy, MD, talks with Endocrine News about the potential of GLP-1s and long-term solutions for childhood obesity. She says a good place to start is creating more programs in schools to help kids eat better and incorporate more...
Weighing In: Making Obesity Treatment More Effective and Accessible by 2030
Endocrine News speaks to the participants of the ENDO 2025 symposium “Future Developments and Challenges in Obesity Treatment: Where Will We Stand at ENDO 2030?” who discuss the future of treating this formidable condition. This July, the year’s biggest event in endocrinology happens in San Francisco, Calif. Although every ENDO is special, ENDO 2025...Harsh Realities: How Treating Obesity Across the Lifespan Continues to Evolve
Fatima Cody Stanford, MD, MPH, MPA, MBA, takes the lessons she learned growing up in Atlanta serving her community and applies them to her work treating obesity. In July, she’ll give the plenary presentation at ENDO 2025, “Changing the Game of Obesity Care Across Lifespan: Policies, Diets, and Drug Innovation,” offering attendees a comprehensive overview...
Yo-Yo Dieting May Significantly Increase Kidney Disease Risk in People with Type 1 Diabetes
Body-weight cycling (also known as yo-yo dieting) has been shown to significantly increase the risk of kidney disease in people with type 1 diabetes, regardless of body mass index (BMI) and other traditional risk factors, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Yo-yo dieting is defined...
All the Rage: Combatting Counterfeit Weight-Loss and Diabetes Drugs
As online ads abound for diabetes and obesity medications, endocrinologists should be prepared to talk to patients who may be attracted to GLP-1 drug lookalikes and supplements from questionable sources. GLP-1 agonists are a cultural phenomenon. Celebrities and social media influencers hyping the drugs’ weight-loss success has led to demand outstripping supply, resulting in shortages...
Do Vitamin D Supplements Lower Blood Pressure in Older People with Obesity?
Vitamin D supplements may lower blood pressure in older people with obesity and taking more than the Institutes of Medicine’s (IOM) recommended daily dose does not provide additional health benefits, according to new research published in the Journal of the Endocrine Society. The IOM recommends 600 International Units (IU) per day. Vitamin D deficiency is common...
Unsolved Mysteries: After Four Decades, Daniel Drucker, MD, Is Still Unlocking Scientific Secrets
The Endocrine Society’s 2025 Fred Conrad Koch Lifetime Achievement Award recipient, Daniel Drucker, MD, first discovered his passion for science in high school when he learned “this is how stuff works.” He’s still learning to this day, and he tells Endocrine News about his ongoing scientific quests, the mentors who made a difference along the...
